C. Haqq

SRY recognizes conserved DNA sites in sex-specific promoters.

C. Haqq, Christina King, P K Donahoe et al. · Proceedings of the National Academy of Sciences · 1993 · 149 citations · Full text

Spermatogenesis, Genetics, Early Male Embryogenesis +19

Evaluation of circulating tumor cell (CTC) enumeration as an efficacy response biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC): Planned final analysis (FA) of COU-AA-301, a randomized, double-blind, placebo-controlled, phase III study of abiraterone acetate (AA) plus low-dose prednisone (P) post docetaxel.

Howard I. Scher, Glenn Heller, Ana M. Molina et al. · Journal of Clinical Oncology · 2011 · 113 citations

Ctc Counts, Cancer Management, Gynecology +18

Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy

Cora N. Sternberg, A. Molina, Scott North et al. · Annals of Oncology · 2012 · 90 citations

Urology, Docetaxel Chemotherapy, Abiraterone Acetate +6

A phase I pharmacokinetic and pharmacodynamic study of AMG 479, a fully human monoclonal antibody against insulin-like growth factor type 1 receptor (IGF-1R), in advanced solid tumors

A. W. Tolcher, Mace L. Rothenberg, Jordi Rodón et al. · Journal of Clinical Oncology · 2007 · 76 citations

Immunology, Immunotherapeutics, Pharmacotherapy +17

Alteration of gene expression profiles of peripheral mononuclear blood cells by tobacco smoke: implications for periodontal diseases

Mark I. Ryder, William C. Hyun, Peter M. Loomer et al. · Oral Microbiology and Immunology · 2003 · 50 citations